학술논문
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
Document Type
Article
Author
Annala, M.; Fu, S.; Bacon, J.V.W.; Sipola, J.; Iqbal, N.; Ferrario, C.; Ong, M.; Wadhwa, D.; Hotte, S.J.; Lo, G.; Tran, B.; Wood, L.A.; Gingerich, J.R.; North, S.A.; Pezaro, C.J.; Ruether, J.D.; Sridhar, S.S.; Kallio, H.M.L.; Khalaf, D.J.; Wong, A.; Beja, K.; Schönlau, E.; Taavitsainen, S.; Nykter, M.; Vandekerkhove, G.; Azad, A.A.; Wyatt, A.W.; Chi, K.N.
Source
In Annals of Oncology July 2021 32(7):896-905
Subject
Language
ISSN
0923-7534